ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Clinical trials for ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy targets Hard-to-Treat kidney cancer
Disease control OngoingThis early-phase study tests an experimental cell therapy called ALLO-316 in adults with advanced or metastatic clear cell kidney cancer who have already tried standard treatments. Participants receive the therapy after a short course of chemotherapy to prepare their immune syste…
Matched conditions: ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated May 17, 2026 09:11 UTC
-
New cell therapy takes on tough kidney cancer
Disease control OngoingThis study tests a new treatment called AB-2100 for people with advanced clear-cell kidney cancer that has come back after other therapies. The treatment uses specially designed immune cells to attack the cancer. The study aims to see if it is safe and whether it can shrink tumor…
Matched conditions: ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Arsenal Biosciences, Inc. • Aim: Disease control
Last updated May 17, 2026 09:09 UTC